FGF21 expression is induced under different disease conditions, such as type 2 diabetes, obesity, chronic kidney diseases, and cardiovascular diseases, and it has a broad spectrum of functions in regulating various metabolic parameters. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.